Lenzing's EUR 301 Million Is Booked — Deutsche Bank's Halved Target Is the Footnote That Matters

Lenzing has banked the money. Whether that money buys anything more than time is the question now sitting in front of every holder of the fibre maker's stock.

The completed rights issue raised gross proceeds of EUR 301.2 million, with existing shareholders taking up 99% of the new shares and the syndicate banks placing the remainder in the market. That closes the financing chapter. It says nothing about the factory floor.

Deutsche Bank Research made its own view plain on Wednesday, reaffirming a "Hold" rating while cutting its price target to EUR 12.70 from EUR 22.00. The halved target is a reminder that a completed capital raise and a better valuation are two different things — and that a large anchor shareholder does not erase re-rating risk.

Two milestones, not one

The distinction investors keep blurring is between a finished funding round and a finished production transfer. Lenzing pushed back the planned closure of its Heiligenkreuz site in the Lafnitztal to the first quarter of 2027, citing the relocation of production to other sites, according to media reports. The delay is neither an all-clear nor proof of failure. It means, for now, that the shutdown is scheduled to happen later.

Should investors sell immediately? Or is it worth buying Lenzing?

That makes execution the real proving ground. Can Lenzing hold the revised timetable? A capital injection can create room to manoeuvre; it cannot by itself confirm that a production handover will work. Anyone who treats the two as the same thing is crediting a financing step with an operational success it has not earned.

Who is standing behind the register

Support from the ownership side remains intact. Following the capital increase, the syndicate of B&C-Gruppe and Suzano S.A. holds roughly 52.25% of voting rights, and Suzano Holding S.A. picked up an additional 0.80% directly. The raise did not dilute the syndicate's majority.

There is insider buying to note as well. Georg Kasperkovitz acquired shares under the subscription rights offering, and Christian Skilich also bought Lenzing stock. Those purchases show the people running the company have skin in the game. They are not, on their own, evidence of future business success.

The bull case needs all three legs

A constructive outcome requires several conditions to line up: the raised capital supports delivery, the major owners keep backing the story, and the production transfer lands on schedule. If those come together, the completed funding round could become a sturdier base for what follows. The progress that matters would then sit in operational execution rather than in the shareholder register.

The bear case is not that the rights issue was pointless. It is that closing it does not remove the operational to-do list. A fresh delay to the transfer would call into question the expectation of an orderly handover — the money would be in the bank while the plant-level change stayed outstanding. Nor should the 99% take-up be mistaken for proof of economic success. It documents a willingness to subscribe, nothing more.

Lenzing at a turning point? This analysis reveals what investors need to know now.

What to watch between now and 2027

The next hard date is the planned closure of Heiligenkreuz in the first quarter of 2027. Company updates on how the transfer is progressing are the likely catalysts before then. For investors, the yardstick is set: not a repeat of the financing announcement, but the move from planning to delivery has to carry the story from here.

As long as the relocation holds to its intended window, the capital strengthening can serve as a foundation for further operational gains. If that window slips again, the positive read-through from the raise would need to be weighted more cautiously. Either way, the decision rests less on any single day's share price move than on whether Lenzing can turn financial backing into visible execution.

Ad

Lenzing Stock: New Analysis - 30 October

Fresh Lenzing information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Lenzing analysis...